|
2026 Journal Article Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from AustralasiaFernandes, Richard Gareth, Kim, Dong Hyun, Ruddick-Collins, Leonie, Vasudevan, Abhinav, Brownson, Anthony Robert, Ngoi, Benjamin, Lin, Chun-Chi, Haifer, Craig, Kim, Dae Sung, Swe, Ei, Wright, Emily Kate, Song, Eun Mi, Mahy, Gillian, Moore, Gregory Thomas, Lee, Hyun Seok, Kim, Hyun Soo, Zhang, Jennifer, Yan Mak, Joyce Wing, Lee, Jun, Lynch, Kate, Gazelakis, Kathryn, Rice, Katie, Kim, Kyeong Ok, Liu, Jing, Lilian Bracken, Lucy Mary, Garg, Mayur, Schultz, Michael, Clark, Nicholas, Cao, Qian ... An, Yoon-Kyo (2026). Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from Australasia. Clinical Gastroenterology and Hepatology, 24 (7), 1916-1927. doi: 10.1016/j.cgh.2025.10.019 |
|
2026 Journal Article Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trialKhoo, Emi, Holtmann, Gerald and Begun, Jakob (2026). Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trial. BMJ Open, 16 (7) e118940, e118940-7. doi: 10.1136/bmjopen-2026-118940 |
|
2026 Journal Article Never‐Smoking Is Associated With Histologic Remission in Ulcerative Colitis: A Post‐Hoc Analysis of the VIEWS Randomised Controlled TrialPudipeddi, Aviv, Pajes, Nico, Paramsothy, Sudarshan, Kariyawasam, Viraj, Paramsothy, Ramesh, Ghaly, Simon, Haifer, Craig, An, Yoon‐Kyo, Begun, Jakob, Connor, Susan J., Corte, Crispin, Ward, Mark G., De Cruz, Peter, Fung, Caroline Lan‐San, Redmond, Diane, Chan, Webber, Mourad, Fadi H., Kermeen, Melissa and Leong, Rupert W. (2026). Never‐Smoking Is Associated With Histologic Remission in Ulcerative Colitis: A Post‐Hoc Analysis of the VIEWS Randomised Controlled Trial. JCC Plus, 1 (4) e70051. doi: 10.1002/jcc5.70051 |
|
2026 Journal Article Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populationsKim, Eun Soo, Kim, Dong Hyun, Kim, Seong-Jung, Park, Sang Hyoung, Lee, Hyun Seok, Kim, Sung Kook, Kim, Hyun Soo, Lee, Jun, Kim, Kyeong Ok, Jang, Byung Ik, Lee, Yoo Jin, Song, Eun Mi, Kim, Dae Sung, Lin, Chun-Chi, Mak, Joyce Wing Yan, Liu, Jing, Cao, Qian, Wei, Shu-Chen, Lin, Wei-Chen, Hsu, Wen-Hung, Sagami, Shintaro, Kobayashi, Taku, Fernandes, Richard G, Gilmore, Robert, An, Yoon-Kyo, Begun, Jakob, Rice, Katie, Ruddick-Collins, Leonie, Vasudevan, Abhinav ... Australia New Zealand IBD Consortium (ANZIBDC) and the Asian Organization for Crohn’s and Colitis (AOCC) (2026). Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations. Inflammatory Bowel Diseases izag098. doi: 10.1093/ibd/izag098 |
|
2026 Journal Article Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Caquilpan, Victor, Wilson, William E., Lynch, Kate D., Ng, Watson, Lawrance, Ian C., Radford-Smith, Graham, Walker, Gareth, Begun, Jakob, Moore, Gregory, Ghaly, Simon, Dutt, Shoma, Giles, Edward, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-992. doi: 10.1016/s0016-5107(26)02519-8 |
|
2026 Journal Article Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Ghali, Mark, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate D., Wark, Gabrielle, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Lawrance, Ian C., Verdon, Christine, Ghaly, Simon, Andrews, Jane and Connor, Susan J. (2026). Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1201. doi: 10.1016/s0016-5107(26)02960-3 |
|
2026 Journal Article Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Su, Wai Kin, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Wark, Gabrielle, Lawrance, Ian C., Begun, Jakob, Haifer, Craig, Radford-Smith, Graham, Walker, Gareth, Shahzad, Asif, Giles, Edward, Dutt, Shoma, Connor, Susan J. and Andrews, Jane (2026). Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1081. doi: 10.1016/s0016-5107(26)02715-x |
|
2026 Journal Article Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMRiley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1082. doi: 10.1016/s0016-5107(26)02717-3 |
|
2026 Journal Article Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMGhali, Mark, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Haifer, Craig, Ng, Watson, Lynch, Kate D., Lawrance, Ian C., Begun, Jakob, Walker, Gareth, Radford-Smith, Graham, Shahzad, Asif, Boyapati, Ray, Verdon, Christine, Connor, Susan J., Andrews, Jane and Ghaly, Simon (2026). Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1204. doi: 10.1016/s0016-5107(26)02967-6 |
|
2026 Journal Article Extended high‐dose tofacitinib induction improves clinical response in ulcerative colitis: a multicenter cohort studyGilmore, R., Pham, T., Fernandes, R. G., Wright, E. K., Lo, S., Rosella, O., De Cruz, P., Andrew, B., Vasudevan, A., Gazelakis, K., Moore, G. T., Thin, L., Au, K., Ghaly, S., Chen, C., Mohsen, W., Goodwin, T., Sparrow, M. P., Ward, M. G., Chew, M., Garg, M., Shelton, E., Lawrance, I. C., Thorat, A., da Fonseca Pereira, C., Begun, J. and An, Y. K. (2026). Extended high‐dose tofacitinib induction improves clinical response in ulcerative colitis: a multicenter cohort study. JGH Open, 10 (5) e70410, 5. doi: 10.1002/jgh3.70410 |
|
2026 Journal Article Development of a novel polyleucine-based immunopotentiator for subunit vaccines against Group A StreptococcusLu, Lantian, Cruz, Jazmina L. Gonzalez, Giri, Rabina, Zhang, Yuexiao, Bashiri, Sahra, Cadena, Leslie C. Domínguez, Li, Shuhang, Khalil, Zeinab G., Hussein, Waleed M., Wang, Jingwen, Kiong, Jolynn, Lu, Xuehan, Zhang, Jiahui, Lu, Miao, Huang, Wenbin, Kong, Wei Yang, Nahar, Ummey Jannatun, Koirala, Prashamsa, Guo, Zhong, Walden, Patricia, Blumenthal, Antje, Begun, Jakob, Alexandrov, Kirill, Toth, Istvan, Stephenson, Rachel J. and Skwarczynski, Mariusz (2026). Development of a novel polyleucine-based immunopotentiator for subunit vaccines against Group A Streptococcus. Small, 22 (22) e11459, 1-20. doi: 10.1002/smll.202511459 |
|
2026 Journal Article Advances in Crohn's disease: A comprehensive review of pathophysiology, diagnosis, and emerging therapeuticsAn, Yoon‐Kyo, Gilmore, Robert, Radford‐Smith, Graham and Begun, Jakob (2026). Advances in Crohn's disease: A comprehensive review of pathophysiology, diagnosis, and emerging therapeutics. JGH Open, 10 (4) e70394, 1-13. doi: 10.1002/jgh3.70394 |
|
2026 Journal Article Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trialJairath, Vipul, Vuyyuru, Sudheer K, Zou, Guangyong, Ma, Christopher, Neustifter, Blue, Agboton, Christian, Romo Bautista, Itzel, Allocca, Mariangela, An, Yoon-Kyo, Begun, Jakob, Bryant, Robert V, Danese, Silvio, Dubinsky, Marla, Feagan, Brian G, Freire, Marcelo, Novak, Kerri L, Panaccione, Remo, Pudipeddi, Aviv, Rubin, David T, Sands, Bruce E, Sparrow, Miles P, Taylor, Stuart A, Gecse, Krisztina B, Wilkens, Rune and Maaser, Christian (2026). Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial. BMJ Open Gastroenterology, 13 (1) e002088, 1-13. doi: 10.1136/bmjgast-2025-002088 |
|
2026 Journal Article DEVELOPMENT OF A NEXT GENERATION ENGINEERED LIVE MICROBIOME BIOTHERAPEUTIC, E COLI NISSLE 1917-TTR, FOR ULCERATIVE COLITISHorgan, Kevin, Barnett, Jacqueline, Godovannyi, Artem, Usakiewicz, Jacek, Adur, Malavika, Mayer, Emeran, Begun, Jakob and Gibson, Deanna (2026). DEVELOPMENT OF A NEXT GENERATION ENGINEERED LIVE MICROBIOME BIOTHERAPEUTIC, E COLI NISSLE 1917-TTR, FOR ULCERATIVE COLITIS. Inflammatory Bowel Diseases, 32 (Supplement_1) izag006.006, 32. doi: 10.1093/ibd/izag006.006 |
|
2026 Journal Article P1007 Evaluation of transmural healing in patients with moderately to severely active Crohn’s disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysisJairath, V, Vuyyuru, S K, Ma, C, Zou, G, Neustifter, B, Agboton, C, Romo Bautista, I, Wu, J J, Jiang, H J, Allocca, M, An, Y K, Begun, J, Bryant, R V, Danese, S, Dubinsky, M C, Freire, M, Novak, K L, Panaccione, R, Pudipeddi, A, Rubin, D T, Sands, B E, Sparrow, M P, Taylor, S A, Gecse, K B, Maaser, C, Feagan, B G and Wilkens, R L (2026). P1007 Evaluation of transmural healing in patients with moderately to severely active Crohn’s disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysis. Journal of Crohn’s and Colitis, 20 (Supplement_1) jjaf231.1188. doi: 10.1093/ecco-jcc/jjaf231.1188 |
|
2026 Journal Article Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologistsChen, Lynna, Ruddick-Collins, Leonie, An, Yoon-Kyo, Baraty, Brandon, Begun, Jakob, Boyapati, Ray K., Bryant, Robert V., Smith, Rebecca L. and Srinivasan, Ashish R. (2026). Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists. Therapeutic Advances in Gastroenterology, 19 17562848261432538, 1-11. doi: 10.1177/17562848261432538 |
|
2026 Journal Article Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: Results from PREDICT-UCLi Wai Suen, Christopher F.D., Choy, Matthew C., Con, Danny, Cheng, Kaylene, Nigro, Julie, Breheney, Kerry, Boyd, Kristy, Pena, Raquel, Burrell, Kathryn, Rosella, Ourania, Proud, David, Brouwer, Richard, Gorelik, Alexandra, Liew, Danny, Connell, William, Wright, Emily K., Taylor, Kirstin, Pudipeddi, Aviv, Sawers, Michelle, Christensen, Britt, Ng, Watson., Begun, Jakob, Radford-Smith, Graham L., Garg, Mayur, Martin, Neal, van Langenberg, Daniel R., Ding, Nik S., Beswick, Lauren, Leong, Rupert W. ... De Cruz, Peter (2026). Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: Results from PREDICT-UC. Gastroenterology, 170 (1), 118-131. doi: 10.1053/j.gastro.2025.07.020 |
|
2026 Journal Article Pathogenic OTUD3 mutations predispose to ulcerative colitis due to barrier dysfunctionGiri, Rabina, Lee, Minyi, Magor, Graham, Bergot, Anne-Sophie, He, Yaowu, Kryza, Thomas, Khan, Tashbib, Schreiber, Veronika, Gordon, Robert J., Zagani, Rachid, Hasnain, Sumaira Z., Lourie, Rohan, Ewing, Adam, Hooper, John D., Thomas, Ranjeny, Florin, Timothy H., Perkins, Andrew, Gala, Manish and Begun, Jakob (2026). Pathogenic OTUD3 mutations predispose to ulcerative colitis due to barrier dysfunction. Cellular and Molecular Gastroenterology and Hepatology, 20 (2) 101659, 1-20. doi: 10.1016/j.jcmgh.2025.101659 |
|
2025 Journal Article Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfactionFernandes, Richard Gareth, Khoo, Emi, Jensen Harris, Heidi, Gilmore, Robert, Khaing, Myat Myat, Ennever, Jenny, Mullen, Kaity, Begun, Jakob and An, Yoon-Kyo (2025). Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfaction. Journal of Crohn's and Colitis, 19 (12) jjaf221. doi: 10.1093/ecco-jcc/jjaf221 |
|
2025 Journal Article Patterns and predictors of steroid use in a real-world inflammatory bowel disease cohortWu, Rodger, Rivas, Consuelo, Su, Wai Kin, Deschenes, Renée, Wilson, William, Pipicella, Joseph L., Connor, Susan J., Andrews, Jane M., An, Yoon-Kyo, Begun, Jakob, Boyapati, Ray, Dutt, Shoma, Gearry, Richard B, Ghaly, Simon, Haifer, Craig, Lawrance, Ian C, Lynch, Kate, Moore, Gregory, Radford-Smith, Graham, Shahzad, Asif, Schultz, Michael, Su, Heidi, Ng, Watson, Verdon, Christine, Walker, Gareth and Wark, Gabrielle (2025). Patterns and predictors of steroid use in a real-world inflammatory bowel disease cohort. JGH Open, 9 (12) e70308, 1-14. doi: 10.1002/jgh3.70308 |
